Quizar 17.7 Price (Generic Quizartinib Bangladesh) – Everest Pharmaceuticals Export

What is Quizar 17.7 (Quizartinib)?

Quizar 17.7 represents a breakthrough in precision oncology for leukemia patients. It is the bioequivalent generic Quizartinib used in combination with standard cytarabine and anthracycline induction and cytarabine consolidation chemotherapy, as well as for maintenance monotherapy.

Patients and hospitals searching for Quizar 17.7 price (generic Quizartinib Bangladesh) are often looking for a sustainable way to access this life-extending treatment. As a second-generation Type II FLT3 inhibitor, Quizar works by blocking the FLT3 receptor signaling, which stops the proliferation of cancer cells.

Clinical Efficacy: The QuANTUM-First Study

Medical transparency builds trust. We reference the major study here.

The approval of Quizartinib was based on the QuANTUM-First Phase 3 trial.

• Survival Benefit: The addition of Quizartinib to standard chemotherapy resulted in a statistically significant improvement in Overall Survival (OS) compared to chemotherapy alone.

• Risk Reduction: It reduced the risk of death by 22% in patients with FLT3-ITD positive AML.

• Durable Response: Patients on maintenance therapy showed prolonged remission durations.

Note: Quizar 17.7 contains the same active ingredient (Quizartinib) as the drug used in these trials.

Indications & Patient Eligibility

Quizar 17.7 is specifically indicated for:

• Adult Patients: With newly diagnosed Acute Myeloid Leukemia (AML).

• FLT3-ITD Positive: Presence of the FLT3 internal tandem duplication (ITD) mutation must be confirmed by a validated test.

• Combination Therapy: Used during induction, consolidation, and as maintenance therapy.

 Safety Profile & Warnings

Crucial for E-E-A-T Compliance.

Before you buy, please review the safety information. Quizar 17.7 is a potent medication.

Boxed Warning (QT Prolongation):

Quizartinib can cause QT prolongation (a heart rhythm condition), torsades de pointes, and cardiac arrest.

• ECG monitoring is mandatory prior to starting treatment and periodically during treatment.

• Correct hypokalemia (low potassium) and hypomagnesemia (low magnesium) before administration.

Common Side Effects:

• Febrile neutropenia (fever with low white blood cells).

• Diarrhea and nausea.

• Mucositis (mouth sores).

• Changes in liver enzymes.

Dosage & Administration

• Induction/Consolidation: The typical dose is 35.4 mg (two 17.7 mg tablets) once daily for 2 weeks in each cycle.

• Maintenance: The typical dose is 26.5 mg once daily.

• Note: Dosage modifications are strict based on QT interval readings. Always follow your oncologist’s protocol.

Price Analysis: Why Choose Generic?

Quizar 17.7 price (generic Quizartinib Bangladesh) is the most searched term for a reason: affordability.

• Global Brand Cost: The reference brand (Vanflyta) can cost upwards of $20,000+ USD per month.

• Everest Pharma Price: Quizar 17.7 offers the same clinical molecule at a fraction of this cost, making long-term maintenance therapy financially viable for self-paying patients.

How to Buy Quizar 17.7 from Everest Pharmaceuticals

We are the official export facilitators for Everest Pharmaceuticals.

1. Request Quote: Click the button above to get the current Quizar 17.7 price.

2. Prescription: A valid prescription from a Hematologist/Oncologist is mandatory.

3. Logistics: We ship via DHL Cold Chain (if required) or standard EMS Priority to ensure product stability.

Technical Specificationn

Specification	Details
Generic Name	Quizartinib
Brand Name	Quizar
Strength	17.7 mg
Dosage Form	Film-Coated Tablet
Manufacturer	Everest Pharmaceuticals Ltd.
Pack Size	28 Tablets (Check Box)
Storage	Store at 20°C to 25°C
Drug Class	Tyrosine Kinase Inhibitor (FLT3)

Frequently Asked Questions (FAQ)

Q: Is Quizar 17.7 the same as Vanflyta?

A: Quizar 17.7 is the generic bioequivalent of Vanflyta. It contains the exact same active ingredient (Quizartinib 17.7mg) and is manufactured by Everest Pharmaceuticals in a WHO-GMP compliant facility.

Q: Why is the Quizar 17.7 price (Generic Quizartinib Bangladesh) so low?

A: Bangladesh operates under WTO-TRIPS patent waivers, allowing the legal manufacturing of patented life-saving drugs for export to LDCs and nations with “Personal Import” laws. This removes the “patent premium” from the cost.

Q: Do you stock the 26.5 mg strength?

A: Yes, we also supply Quizar 26.5 mg. Please specify the strength required in your inquiry form.

Q: How do you monitor the QT prolongation risk during shipping?

A: We do not monitor patients; that is your doctor’s role. We handle the logistics of getting the medicine to you safely. We recommend you share the technical sheet with your cardiologist.